Despite the shortage of direct evidence between excessive mGluR-LTD and elevated forgetting in AD, the finding that hippocampal mGluR-LTD are altered in animal models of AD has led to novel therapeutics for this disease acting at mGluR5. The gene discussed is GRM5; the disease is Alzheimer disease.